158 related articles for article (PubMed ID: 4791683)
1. Dose-dependent drug metabolism during the absorptive phase.
Barr WH; Aceto T; Chung M; Shukur M
Rev Can Biol; 1973; 32():Suppl:33-42. PubMed ID: 4791683
[No Abstract] [Full Text] [Related]
2. Proceedings: Bioavailability and therapeutic efficacy.
Withey RJ
Rev Can Biol; 1973; 32():Suppl:21-30. PubMed ID: 4777602
[No Abstract] [Full Text] [Related]
3. Bioavailability, clinical effectiveness, and the public interest.
Levy G
Pharmacology; 1972; 8(1):33-43. PubMed ID: 4644654
[No Abstract] [Full Text] [Related]
4. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
Schumacher GE
Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
[No Abstract] [Full Text] [Related]
5. [Pharmacology and practical therapy. Principles for the selection of application form of a drug and its mode of origin].
Levy G; Barr WH
Internist (Berl); 1973 Dec; 14(12):661-7. PubMed ID: 4593013
[No Abstract] [Full Text] [Related]
6. Bioavailability of peroral dosage forms.
Ritschel WA
Boll Chim Farm; 1973 Mar; 112(3):137-62. PubMed ID: 4198518
[No Abstract] [Full Text] [Related]
7. Regional intestinal drug permeation: biopharmaceutics and drug development.
Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of drugs (first of two parts).
Koch-Weser J
N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
[No Abstract] [Full Text] [Related]
9. Proceedings: Mechanisms of drug absorption and of drug solution.
Jollow DJ
Rev Can Biol; 1973; 32():Suppl:7-19. PubMed ID: 4777606
[No Abstract] [Full Text] [Related]
10. Effect of route of administration on drug disposition.
Riegelman S; Rowland M
J Pharmacokinet Biopharm; 1973 Oct; 1(5):419-34. PubMed ID: 4787618
[No Abstract] [Full Text] [Related]
11. Bioequivalence of drug products.
Koritz GD
J Am Vet Med Assoc; 1980 Aug; 177(3):279-81. PubMed ID: 7440334
[No Abstract] [Full Text] [Related]
12. Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.
Lennernäs H; Aarons L; Augustijns P; Beato S; Bolger M; Box K; Brewster M; Butler J; Dressman J; Holm R; Julia Frank K; Kendall R; Langguth P; Sydor J; Lindahl A; McAllister M; Muenster U; Müllertz A; Ojala K; Pepin X; Reppas C; Rostami-Hodjegan A; Verwei M; Weitschies W; Wilson C; Karlsson C; Abrahamsson B
Eur J Pharm Sci; 2014 Jun; 57():292-9. PubMed ID: 24189462
[TBL] [Abstract][Full Text] [Related]
13. Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms.
Akers MJ
Int J Pharm Compd; 2017; 21(1):47-56. PubMed ID: 28346198
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic non-equivalence.
Br Med J; 1972 Sep; 3(5827):599-600. PubMed ID: 5071688
[No Abstract] [Full Text] [Related]
15. The use of physical and animal models to assess bioavailability.
Barr WH
Pharmacology; 1972; 8(1):55-101. PubMed ID: 4630161
[No Abstract] [Full Text] [Related]
16. Bioavailability from pharmaceutical dosage forms.
Stenlake JB
Analyst; 1974 Dec; 99(1185):824-37. PubMed ID: 4462405
[No Abstract] [Full Text] [Related]
17. Drug dosage forms: part one.
Aust Nurses J; 1984 Feb; 13(7):36, 52. PubMed ID: 6561028
[No Abstract] [Full Text] [Related]
18. [Influence of the starting materials on bioavailability of drugs].
Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
[No Abstract] [Full Text] [Related]
19. Paediatric oral biopharmaceutics: key considerations and current challenges.
Batchelor HK; Fotaki N; Klein S
Adv Drug Deliv Rev; 2014 Jun; 73():102-26. PubMed ID: 24189013
[TBL] [Abstract][Full Text] [Related]
20. Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
Chen ML
Clin Pharmacol Ther; 2005 Oct; 78(4):322-9. PubMed ID: 16198651
[No Abstract] [Full Text] [Related]
[Next] [New Search]